Cargando…
Serum sST2 levels predict severe exacerbation of asthma
BACKGROUND: Neutrophilic inflammation is associated with poorly controlled asthma. Serum levels of sST2, a soluble IL-33 receptor, increase in neutrophilic lung diseases. We hypothesized that high serum sST2 levels in stable asthmatics are a predictor for exacerbation within a short duration. METHOD...
Autores principales: | Watanabe, Masato, Nakamoto, Keitaro, Inui, Toshiya, Sada, Mitsuru, Honda, Kojiro, Tamura, Masaki, Ogawa, Yukari, Yokoyama, Takuma, Saraya, Takeshi, Kurai, Daisuke, Ishii, Haruyuki, Takizawa, Hajime |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6126416/ https://www.ncbi.nlm.nih.gov/pubmed/30176857 http://dx.doi.org/10.1186/s12931-018-0872-2 |
Ejemplares similares
-
Ruxolitinib inhibits poly(I:C) and type 2 cytokines‐induced CCL5 production in bronchial epithelial cells: A potential therapeutic agent for severe eosinophilic asthma
por: Sada, Mitsuru, et al.
Publicado: (2021) -
Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases
por: Saraya, Takeshi, et al.
Publicado: (2018) -
A Novel Diagnostic Scoring System to Differentiate between Legionella pneumophila Pneumonia and Streptococcus pneumoniae Pneumonia
por: Saraya, Takeshi, et al.
Publicado: (2018) -
Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs
por: Watanabe, Masato, et al.
Publicado: (2022) -
Virus-induced exacerbations in asthma and COPD
por: Kurai, Daisuke, et al.
Publicado: (2013)